Adempas not for use in patients with pulmonary hypertension caused by idiopathic interstitial pneumonia

View source ↗

Summary

The EMA guidance states that Adempas (riociguat) should not be used in patients with pulmonary hypertension due to idiopathic interstitial pneumonia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Idiopathic Interstitial Pneumonia
• Pulmonary Hypertension

Drugs mentioned

• Adempas (riociguat)